AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

656.138

-6.217-0.94%

Number of Gainers:8

Number of Losers:17

Number of Flat:18

PE:- -

High:666.258

Open:660.539

Low:655.395

Close:662.355

Volume:61.41M

Turnover:116.52M

Market Cap:92.69B

Float Cap:89.39B

Loading ...

Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million

Proteomics International Laboratories - FY Revenue A$3.6 Mln

THOMSON REUTERS

Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Tissue Repair Posts FY Loss Attributable of A$5.4 Million

Tissue Repair Ltd - FY Revenues from Ordinary Activities A$3.2 Mln

THOMSON REUTERS

Tissue Repair - no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically

Simply Wall St.

Cann Group Ltd-Preliminary Final Report

THOMSON REUTERS

Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026

THOMSON REUTERS

Australia's Immutep Falls to Near 3-Week Low as 2026 Loss Widens

Orthocell Ltd - no Dividends Have Been Declared

THOMSON REUTERS

Orthocell Ltd - FY Revenue from Ordinary Activities A$11.4 Mln

THOMSON REUTERS

Immutep Says no Dividends Paid or Declared During Current FY

Cynata Therapeutics - no Dividends Declared for Fy2026

THOMSON REUTERS

Cynata Therapeutics - Fy2026 Loss from Ordinary Activities After Tax A$9.1 Mln

THOMSON REUTERS

Anteotech Ltd - FY Revenues from Ordinary Activities A$467,589

THOMSON REUTERS

Anteotech Ltd - Loss for Year Attributable A$4.9 Mln

THOMSON REUTERS

Immutep - FY Loss Attributable A$79.3 Mln

THOMSON REUTERS

Spotlight for Clinuvel Turning to Vitiligo Trial Readout

Monash IVF Group - Appoints Catherine West as Chair-Elect to Succeed Richard Davis as Chair

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":656.13776,"timestamp":1788155999504,"preClose":662.35516,"halted":0,"volume":61408438,"delay":0,"changeRate":-0.009387,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-6.217407,"latestTime":"08-31 16:00:00 AEST","open":660.5389,"high":666.2579,"low":655.3953,"amount":116520727,"amplitude":0.0164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788134400000,1788156000000]],"turnoverRate":0.002409,"increases":7,"decrements":17,"flats":19,"marketCap":92694912137.5,"floatMarketCap":89392893767.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":666.2579,"amplitude":0.0164,"preClose":662.35516,"low":655.3953,"latestPrice":656.13776,"volume":61408438,"delay":0,"open":660.5389,"prevYearClose":644.3692,"prevWeekClose":662.355,"prevMonthClose":488.077,"prevQuarterClose":464.145,"fiveDayClose":657.516,"twentyDayClose":493.047,"sixtyDayClose":409.453,"secType":"PLATE","market":"AU","turnoverRate":0.002409,"marketCap":92694912137.5,"floatMarketCap":89392893767.375,"timestamp":1788155999504,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":8,"down":17,"flat":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663784060","title":"Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663784060","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663784060?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:44","pubTimestamp":1788162262,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Posts FY Loss Attributable A$8.6 MillionAug 31 -Proteomics International Laboratories LtdPIQ.AX:FY LOSS ATTRIBUTABLE A$8.6 MILLIONFY REVENUE A$3.6 MILLIONTHERE WERE NO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFurther company coverage:PIQ.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","PIQ.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663272890","title":"Proteomics International Laboratories - FY Revenue A$3.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663272890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663272890?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:40","pubTimestamp":1788158409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663027285","title":"Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663027285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663027285?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:40","pubTimestamp":1788158409,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022015","title":"Tissue Repair Posts FY Loss Attributable of A$5.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022015?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:13","pubTimestamp":1788156830,"startTime":"0","endTime":"0","summary":"BRIEF-Tissue Repair Posts FY Loss Attributable Of A$5.4 MillionAug 31 (Reuters)-Tissue Repair LtdTRP.AX:FY REVENUES FROM ORDINARY ACTIVITIES A$3.2 MILLIONFY LOSS ATTRIBUTABLE A$5.4 MILLIONNO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFurther company coverage:TRP.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TRP.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663220680","title":"Tissue Repair Ltd - FY Revenues from Ordinary Activities A$3.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663220680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663220680?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:12","pubTimestamp":1788156734,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRP.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663065022","title":"Tissue Repair - no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663065022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663065022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:12","pubTimestamp":1788156734,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRP.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663607448","title":"Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically","url":"https://stock-news.laohu8.com/highlight/detail?id=2663607448","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663607448?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:37","pubTimestamp":1788151054,"startTime":"0","endTime":"0","summary":"One thing we could say about the analysts on Mesoblast Limited ( ASX:MSB ) - they aren't optimistic, having just made a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021480","title":"Cann Group Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021480?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","CAN.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002145","title":"Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002145?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAN.AU","BK7096","BK7508","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021517","title":"Australia's Immutep Falls to Near 3-Week Low as 2026 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021517?lang=en_us&edition=fundamental","pubTime":"2026-08-31 11:40","pubTimestamp":1788147609,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immutep falls to near 3-week low as 2026 loss widens** Shares of ImmutepIMM.AXfell as much as 4% to A$0.048, marking their lowest level since August 12** Biotechnology firm'sannual losswidens by 29.1% to A$79.3 million  from A$61.4 million in 2025** Including day's moves, stock down 88.2% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S09S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663647029","title":"Orthocell Ltd - no Dividends Have Been Declared","url":"https://stock-news.laohu8.com/highlight/detail?id=2663647029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663647029?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:59","pubTimestamp":1788145149,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","OCC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663029642","title":"Orthocell Ltd - FY Revenue from Ordinary Activities A$11.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663029642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663029642?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:59","pubTimestamp":1788145149,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","OCC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663025976","title":"Immutep Says no Dividends Paid or Declared During Current FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2663025976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663025976?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:32","pubTimestamp":1788139963,"startTime":"0","endTime":"0","summary":"BRIEF-Immutep Says No Dividends Paid Or Declared During Current FYAug 31 (Reuters)-Immutep LtdIMM.AX:IMMUTEP LTD -  NO DIVIDENDS PAID OR DECLARED DURING CURRENT FYFurther company coverage:IMM.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P20Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663284430","title":"Cynata Therapeutics - no Dividends Declared for Fy2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663284430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663284430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:10","pubTimestamp":1788135014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R037:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","CYP.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028432","title":"Cynata Therapeutics - Fy2026 Loss from Ordinary Activities After Tax A$9.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663028432?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:10","pubTimestamp":1788135014,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","BK7508","CYP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407270","title":"Anteotech Ltd - FY Revenues from Ordinary Activities A$467,589","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663407270?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:31","pubTimestamp":1788132711,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nFWN44P210:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BK7036","ADO.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040720","title":"Anteotech Ltd - Loss for Year Attributable A$4.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040720?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:31","pubTimestamp":1788132711,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nFWN44P210:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7036","BK7501","BK7508","ADO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040149","title":"Immutep - FY Loss Attributable A$79.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040149?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:14","pubTimestamp":1788131660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nPLXZ3JZPT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040960","title":"Spotlight for Clinuvel Turning to Vitiligo Trial Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040960","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040960?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:01","pubTimestamp":1788130860,"startTime":"0","endTime":"0","summary":"2300 GMT - The spotlight for Clinuvel Pharmaceuticals is increasingly turning to the readout of the CUV105 trial, says Jefferies. It is due by the end of December. Clinuvel is currently involved in a Phase 3 clinical trial of afamelanotide as a potential treatment for vitiligo, which affects some 0.75% of the U.S. population. Current treatment options are suboptimal, analyst David Stanton says. Vitiligo is a repigmentation disease with a large total addressable market of up to US$570 million in the first two years of entry to the market. \"Given Phase 2 trial results, we believe afamelanotide may eventually offer a more definitive, full-body solution than current standards of care in vitiligo,\" says Jefferies, which has a buy call on Clinuvel.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUV.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663470080","title":"Monash IVF Group - Appoints Catherine West as Chair-Elect to Succeed Richard Davis as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2663470080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663470080?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:30","pubTimestamp":1788129048,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE3YWG98:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVF.AU","BK7508","BK7113"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":155,"code":"91000000","status":"200"}]}}